A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting

Author: McCullagh Laura   Tilson Lesley   Walsh Cathal   Barry Michael  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.27, Iss.10, 2009-10, pp. : 829-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract